Analysis of the B-cell repertoire against antigens expressed by human neoplasms

Immunological Reviews

Volumn 188, Issue , 2002, Pages 43-50

  Preuss, Klaus Dieter ^a   Zwick, Carsten ^a   Bormann, Claudia ^a   Neumann, Frank ^a   Pfreundschuh, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CANCER TESTIS ANTIGEN; CANCER VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; HOM TES14 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MAGE ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; ALLOANTIBODY; AUTOANTIBODY; CANCER ANTIBODY; COMPLEMENTARY DNA; HYBRID PROTEIN; MESSENGER RNA;

ANTIBODY TITER; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; DNA LIBRARY; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR RECOGNITION; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; SEROLOGICAL EXPRESSION CLONING; TISSUE SPECIFICITY; TUMOR CELL CULTURE; VACCINATION; ANTIBODY SPECIFICITY; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FACTUAL DATABASE; GENE LIBRARY; GENETICS; IMMUNOLOGY; MOLECULAR CLONING; NEOPLASM; REVIEW;

ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; AUTOANTIBODIES; B-LYMPHOCYTES; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONING, MOLECULAR; DATABASES, FACTUAL; DNA, COMPLEMENTARY; GENE LIBRARY; HUMANS; ISOANTIBODIES; NEOPLASMS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER;

EID: 0036812659     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.18805.x     Document Type: Article

References (41)

1. Maloney DG, et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997;90:2188-2195.
2. Old LJ. Cancer immunology: The search for specificity - G. H. A. Clowes Memorial Lecture. Cancer Res 1981;41:361-375.
3. van der Bruggen P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-1647.
4. Sahin U, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995;92:11810-11813.
5. Sahin U, Tureci O, Pfreundschuh M. Serological identification of human tumor antigens. Curt Opin Immunol 1997;9:709-716.
6. Tureci O, et al. Human carbonic anhydrase XII. cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 1998;95:7608-7613.
7. Tureci O, et al. The SSX-2 gene, which is involved in the t(X; 18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996;56:4766-4772.
8. Gure AO, et al. CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 2000;85:726-732.
9. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998;95:5211-5216.
10. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 1997;6:33-39.
11. Chen YT, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997;94:1914-1918.
12. Boel P, et al. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-175.
13. Van EB, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995;182:689-698.
14. Clark J, et al. Identification of novel genes, SYT and SSX, involved in the t(X; 18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-508.
15. Gure AO, et al. SSX: A multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997;72:965-971.
16. Tureci O, et al. Expression of SSX genes in human tumors. Int J Cancer 1998;77:19-23.
17. Lethe B, et al. LAGE-1, a new gene with tumor specificity. Int J Cancer 1998;76:903-908.
18. Jager E, et al. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998;187:265-270.
19. Jager E, et al. Humoral immune responses of cancer patients against 'Cancer-Testis' antigen NY-ESO-1: Correlation with clinical events. Int J Cancer 1999;84:506-510.
20. Stockert E, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998;187:1349-1354.
21. Eichmuller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci USA 2001;98:629-634.
22. Huang S, Preuss KD, Xie X, Regitz E, Pfreundschuh M. Analysis of the antibody repertoire of lymphoma patients. Cancer Immunol Immunother, in press.
23. Schmits R, et al. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer 2002;98:73-77.
24. Scanlan MJ, et al. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998;76:652-658.
25. Pierre P, Scheel J, Rickard JE, Kreis TE. CLIP-170 links endocytic vesicles to microtubules. Cell 1992;70:887-900.
26. Steuner-Liewen F, et al. Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2000;9:285-290.
27. Obata Y, et al. SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol 2000;46:S37-S42.
28. Jager E, et al. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med 2000;191:625-630.
29. Ayyoub M, et al. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. J Immunol 2002;168:1717-1722.
30. Ivanov SV, et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 1998;95:12596-12601.
31. Parkkila S, et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 2000;97:2220-2224.
32. Matzinger P. The danger model: A renewed sense of self. Science 2002;296:301-305.
33. Xie X, Renner C, Preuss KD, Pfreundschuh M. Systematic search and molecular characterization of the antigenic targets of myeloma immunoglobulins: A monoclonal IgA from a female patient targeting sperm-specific cyclicin II. Cancer Immunity 2002;1:11-19.
34. Doyle HA, Mamula MJ. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 2001;22:443-449.
35. Stoltze L, et al. Two new proteases in the MHC class I processing pathway. Nat Immunol 2000;1:413-418.
36. Valmori D, et al. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. Cancer Res 1999;59:4050-4055.
37. Haurum JS, et al. Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med 1999;190:145-150.
38. Old LJ, Chen YT. New paths in human cancer serology. J Exp Med 1998;187:1163-1167.
39. Hofbauer GF, et al. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution. Am J Pathol 1997;151:1549-1553.
40. Jungbluth AA, et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856-860.
41. Xie X, et al. Expression of cancer germline genes in non-Hodgkin's lymphomas. Clin Cancer Res 2002, in press.